To validate experimentally the discovered regulatory link, we evaluated ANXA2R and FOXM1 expression levels in different glioma cells: LN18, LN229, U87 established glioma cell lines, patient-derived WG4, IPIN glioma cell cultures35 and normal human astrocytes (NHA) using quantitative PCR (qPCR). The gene discussed is ANXA2R; the disease is central nervous system cancer.